Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 5 | 2021 | 312 | 1.250 |
Why?
|
| Hypertrophy, Right Ventricular | 5 | 2013 | 33 | 1.210 |
Why?
|
| Dynamins | 3 | 2024 | 50 | 1.000 |
Why?
|
| Dichloroacetic Acid | 2 | 2017 | 12 | 0.930 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 429 | 0.810 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2024 | 59 | 0.810 |
Why?
|
| Hypertension, Pulmonary | 7 | 2015 | 381 | 0.730 |
Why?
|
| Mitochondria | 2 | 2020 | 623 | 0.720 |
Why?
|
| Myocardial Stunning | 1 | 2020 | 12 | 0.640 |
Why?
|
| Electron Transport Complex I | 1 | 2020 | 34 | 0.630 |
Why?
|
| Superoxides | 1 | 2020 | 76 | 0.630 |
Why?
|
| Hydrogen Peroxide | 1 | 2020 | 165 | 0.610 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2017 | 13 | 0.540 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 91 | 0.510 |
Why?
|
| Glucose | 4 | 2021 | 701 | 0.490 |
Why?
|
| Mitochondrial Dynamics | 3 | 2024 | 59 | 0.400 |
Why?
|
| Xanthenes | 1 | 2012 | 23 | 0.390 |
Why?
|
| Glutamine | 1 | 2013 | 99 | 0.390 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2012 | 24 | 0.380 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2012 | 34 | 0.380 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2012 | 73 | 0.380 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2021 | 248 | 0.380 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 180 | 0.360 |
Why?
|
| Animals | 20 | 2025 | 28945 | 0.340 |
Why?
|
| Rats | 10 | 2020 | 4154 | 0.340 |
Why?
|
| Heart Ventricles | 2 | 2013 | 810 | 0.330 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 517 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 3490 | 0.290 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2020 | 141 | 0.280 |
Why?
|
| Mice | 9 | 2025 | 12562 | 0.280 |
Why?
|
| Oxidation-Reduction | 4 | 2013 | 411 | 0.280 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2020 | 243 | 0.270 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 340 | 0.270 |
Why?
|
| Myocytes, Cardiac | 3 | 2024 | 324 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2015 | 1267 | 0.260 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 147 | 0.240 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2025 | 14 | 0.230 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 26 | 0.210 |
Why?
|
| Mitochondria, Heart | 1 | 2024 | 52 | 0.210 |
Why?
|
| Hypoxia | 3 | 2020 | 682 | 0.200 |
Why?
|
| Vascular Remodeling | 2 | 2020 | 23 | 0.190 |
Why?
|
| GTP Phosphohydrolases | 2 | 2013 | 82 | 0.180 |
Why?
|
| Random Allocation | 2 | 2020 | 327 | 0.180 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2551 | 0.180 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 129 | 0.180 |
Why?
|
| Homeostasis | 1 | 2024 | 467 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2025 | 3586 | 0.170 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 70 | 0.170 |
Why?
|
| Familial Primary Pulmonary Hypertension | 4 | 2013 | 65 | 0.170 |
Why?
|
| Receptors, Prostaglandin | 1 | 2020 | 7 | 0.160 |
Why?
|
| Hemodynamics | 2 | 2017 | 781 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 45 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2011 | 153 | 0.160 |
Why?
|
| Heart Failure | 1 | 2010 | 1422 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 145 | 0.150 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2019 | 27 | 0.150 |
Why?
|
| Calcium | 1 | 2024 | 1205 | 0.150 |
Why?
|
| Neointima | 1 | 2018 | 14 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 22 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2018 | 91 | 0.140 |
Why?
|
| Quinazolinones | 2 | 2015 | 15 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1761 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2020 | 527 | 0.120 |
Why?
|
| Receptors, Prostaglandin E, EP3 Subtype | 1 | 2015 | 1 | 0.110 |
Why?
|
| Positron-Emission Tomography | 2 | 2021 | 354 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 57 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 90 | 0.110 |
Why?
|
| Cell Movement | 1 | 2018 | 820 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1773 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2015 | 2943 | 0.100 |
Why?
|
| Diazooxonorleucine | 1 | 2013 | 7 | 0.100 |
Why?
|
| Male | 10 | 2025 | 45870 | 0.100 |
Why?
|
| Survival Rate | 1 | 2017 | 1986 | 0.100 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 48 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 29 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 1 | 2012 | 20 | 0.100 |
Why?
|
| Dobutamine | 1 | 2012 | 62 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 152 | 0.090 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 27 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 184 | 0.090 |
Why?
|
| Female | 6 | 2021 | 50063 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 95 | 0.090 |
Why?
|
| Mitosis | 1 | 2012 | 159 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2012 | 253 | 0.090 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2012 | 123 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2025 | 2163 | 0.090 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
|
| Dopamine | 1 | 2012 | 282 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 187 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 32 | 0.080 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2012 | 167 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 701 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 273 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 741 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2013 | 684 | 0.080 |
Why?
|
| Pulmonary Artery | 3 | 2020 | 341 | 0.080 |
Why?
|
| Humans | 11 | 2025 | 96127 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2010 | 482 | 0.070 |
Why?
|
| Macrophages | 1 | 2010 | 626 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 188 | 0.060 |
Why?
|
| Models, Biological | 1 | 2013 | 1815 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 204 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 788 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2013 | 1730 | 0.060 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 264 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2059 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2025 | 482 | 0.050 |
Why?
|
| Myocardium | 1 | 2025 | 596 | 0.050 |
Why?
|
| Glycolysis | 2 | 2012 | 192 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 297 | 0.040 |
Why?
|
| Microglia | 1 | 2021 | 124 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2020 | 68 | 0.040 |
Why?
|
| Epoprostenol | 1 | 2020 | 46 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 104 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 112 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2019 | 46 | 0.040 |
Why?
|
| Sirolimus | 1 | 2020 | 177 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 439 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 264 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 706 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.030 |
Why?
|
| Lung | 2 | 2013 | 1382 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 995 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 138 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 88 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 280 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 130 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2092 | 0.030 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 18 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 259 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 65 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2794 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2015 | 338 | 0.020 |
Why?
|
| Monocrotaline | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2012 | 17 | 0.020 |
Why?
|
| Cobalt | 1 | 2012 | 31 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2012 | 47 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1068 | 0.020 |
Why?
|
| Ranolazine | 1 | 2011 | 4 | 0.020 |
Why?
|
| Acetanilides | 1 | 2011 | 6 | 0.020 |
Why?
|
| Trimetazidine | 1 | 2011 | 4 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 108 | 0.020 |
Why?
|
| Hexokinase | 1 | 2011 | 22 | 0.020 |
Why?
|
| Glycogen | 1 | 2011 | 60 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2011 | 46 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 385 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 257 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2010 | 66 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 151 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 172 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 89 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 692 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 124 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 909 | 0.020 |
Why?
|
| Ventricular Function, Right | 1 | 2011 | 160 | 0.020 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 50 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 2482 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 296 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2012 | 382 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1157 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 407 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 657 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1958 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1568 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1763 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1276 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2883 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 5585 | 0.010 |
Why?
|